Imipenem-Cilastatin versus Sulbactam-Cefoperazone plus Amikacin in the Initial Treatment of Febrile Neutropenic Cancer Patients

por ÖZYILKAN, Özgür, YALÇINTAŞ, ÜlKü, BAŞKAN, Sezgin
Publicado 1999

Malignant pleural mesothelioma: A single-center experience in Turkey

por Sezer, Ahmet, Sümbül, Ahmet Taner, Abalı, Hüseyin, Mertsoylu, Hüseyin, Özyılkan, Özgür
Publicado 2014

The effect of HER2 expression on cisplatin-based chemotherapy in advanced non-small cell lung cancer patients

por Calikusu, Zuleyha, Yildirim, Yesim, Akcali, Zafer, Sakalli, Hakan, Bal, Nebil, Unal, Ilker, Ozyilkan, Ozgur
Publicado 2009

Cardiotoxicity of trastuzumab emtansine (T-DM1): a single-center experience

por Acibuca, Aynur, Sezer, Ahmet, Yilmaz, Mustafa, Sumbul, Ahmet Taner, Demircan, Senol, Muderrisoglu, Ibrahim Haldun, Ozyilkan, Ozgur
Publicado 2021

An old enemy not to be forgotten during PET CT scanning of cancer patients: tuberculosis

por Sümbül, Ahmet Taner, Sezer, Ahmet, Abali, Hüseyin, Gültepe, Bilge, Koçer, Emrah, Reyhan, Mehmet, Tonyalı, Önder, Özyilkan, Özgür
Publicado 2014

Prognostic Usefulness Of Advanced Lung Cancer Inflammation Index In Locally-Advanced Pancreatic Carcinoma Patients Treated With Radical Chemoradiotherapy

por Topkan, Erkan, Mertsoylu, Huseyin, Ozdemir, Yurday, Sezer, Ahmet, Kucuk, Ahmet, Besen, Ali Ayberk, Ozyilkan, Ozgur, Selek, Ugur
Publicado 2019

Can serial monitoring of serum Vascular Endothelial Growth Factor (VEGF), Nitric Oxide (NO), and Angiotensin II (ANGII) levels have predictive role during Bevacizumab treatment?

por Sümbül, Ahmet Taner, Dişel, Umut, Sezgin, Nurzen, Sezer, Ahmet, Köse, Fatih, Beşen, Ali Ayberk, Sümbül, Zehra, Abalı, Hüseyin, Özyılkan, Özgür
Publicado 2014

A national, multicenter, non-interventional, observational study on treatment patterns in patients with metastatic renal cell carcinoma in Turkey – NOTES study

por Yalçın, Şuayib, Yildiz, Ramazan, Dane, Faysal, Karaoğlu, Aziz, Öksüzoğlu, Berna, Özyılkan, Özgür, Sevinç, Alper, Özdemir, Feyyaz, Turna, Hande, Uslu, Rüçhan, Ulay, Esat
Publicado 2018

Risk Factors for Fatal Pulmonary Hemorrhage following Concurrent Chemoradiotherapy in Stage 3B/C Squamous-Cell Lung Carcinoma Patients

por Topkan, Erkan, Selek, Ugur, Ozdemir, Yurday, Besen, Ali A., Guler, Ozan C., Yildirim, Berna A., Mertsoylu, Huseyin, Findikcioglu, Alper, Ozyilkan, Ozgur, Pehlivan, Berrin
Publicado 2018

Prechemoradiotherapy Systemic Inflammation Response Index Stratifies Stage IIIB/C Non-Small-Cell Lung Cancer Patients into Three Prognostic Groups: A Propensity Score-Matching Anal...

por Topkan, Erkan, Selek, Ugur, Kucuk, Ahmet, Haksoyler, Veysel, Ozdemir, Yurday, Sezen, Duygu, Mertsoylu, Huseyin, Besen, Ali Ayberk, Bolukbasi, Yasemin, Ozyilkan, Ozgur, Pehlivan, Berrin
Publicado 2021

nextMONARCH Phase 2 randomized clinical trial: overall survival analysis of abemaciclib monotherapy or in combination with tamoxifen in patients with endocrine-refractory HR + , HE...

por Hamilton, Erika, Cortes, Javier, Ozyilkan, Ozgur, Chen, Shin-Cheh, Petrakova, Katarina, Manikhas, Aleksey, Jerusalem, Guy, Hegg, Roberto, Huober, Jens, Zhang, Wei, Chen, Yanyun, Martin, Miguel
Publicado 2022

Concurrent Chemoradiotherapy with Vinorelbine plus Split-Dose Cisplatin may be an Option in Inoperable Stage III Non-Small Cell Lung Cancer: A Single-Center Experience

por Mertsoylu, Hüseyin, Köse, Fatih, Sümbül, Ahmet Taner, Sedef, Ali Murat, Doğan, Özlem, Besen, Ali Ayberk, Parlak, Cem, Fındıkçıoğlu, Alper, Muallaoğlu, Sadık, Sezer, Ahmet, Sakallı, Hakan, Özyılkan, Özgür
Publicado 2015

Efficacy and safety of trifluridine/tipiracil in older and younger patients with metastatic gastric or gastroesophageal junction cancer: subgroup analysis of a randomized phase 3 s...

por Shitara, Kohei, Doi, Toshihiko, Hosaka, Hisashi, Thuss-Patience, Peter, Santoro, Armando, Longo, Federico, Ozyilkan, Ozgur, Cicin, Irfan, Park, David, Zaanan, Aziz, Pericay, Carles, Özgüroğlu, Mustafa, Alsina, Maria, Makris, Lukas, Benhadji, Karim A., Ilson, David H.
Publicado 2022